Human PTHrP-(1-36) stands as a paramount peptide analog, extensively employed in the realm of biomedical research. It exerts its influence as a parathyroid hormone-related protein receptor agonist, duly contributing to the maintenance of calcium homeostasis and the intricate regulation of bone metabolism.
Human PTHrP-(1-36), or human parathyroid hormone-related protein fragment 1-36, is a synthetic peptide corresponding to the biologically active N-terminal region of the endogenous PTHrP molecule. As a member of the parathyroid hormone family, this peptide exhibits significant homology to parathyroid hormone (PTH) and is recognized for its potent agonist activity at the PTH1 receptor. Its sequence confers the ability to mimic the physiological actions of native PTHrP, making it a valuable molecular tool in the study of calcium homeostasis, bone remodeling, and cellular signaling pathways. Human PTHrP-(1-36) is widely utilized in biochemical and cellular research to unravel the mechanistic roles of PTHrP in development, differentiation, and tissue-specific functions.
Receptor signaling research: Human PTHrP-(1-36) serves as a robust agonist for the PTH1 receptor, enabling detailed investigation of receptor-mediated signaling cascades in target cells. By selectively activating this G protein-coupled receptor, researchers can dissect downstream pathways involving cyclic AMP, phospholipase C, and MAP kinase activities. The peptide's defined sequence and receptor specificity facilitate precise studies of ligand-receptor interactions, receptor desensitization, and the modulation of gene expression linked to calcium and phosphate metabolism.
Bone biology studies: The peptide is extensively employed in experimental models to elucidate the role of PTHrP in bone formation, resorption, and remodeling. Its ability to stimulate osteoblastic activity and influence osteoclastogenesis makes it instrumental in exploring skeletal development and the dynamic balance between bone deposition and degradation. Investigations using this fragment provide insights into the molecular mechanisms underlying bone density regulation, growth plate physiology, and the paracrine/autocrine actions of PTHrP in osseous tissues.
Cell differentiation assays: Human PTHrP-(1-36) is frequently used to modulate the differentiation of various cell types, particularly in studies involving chondrocytes, osteoblasts, and mesenchymal stem cells. By acting on lineage-specific signaling pathways, it enables researchers to probe the regulatory networks that control cellular maturation, proliferation, and phenotype commitment. Such applications are critical for understanding tissue-specific effects of PTHrP in development, regeneration, and pathological conditions.
Calcium homeostasis modeling: The peptide fragment is an essential tool for modeling the regulation of calcium transport and homeostasis in vitro. Its capacity to mimic endogenous PTHrP actions allows for controlled manipulation of calcium flux, transporter activity, and calcium-sensing receptor responses in cell culture systems. These models are vital for delineating the physiological and pathophysiological roles of PTHrP in mineral ion balance across various organ systems.
Peptide structure-function analysis: Human PTHrP-(1-36) is utilized in structure-activity relationship (SAR) studies aimed at identifying key residues responsible for receptor binding and biological efficacy. Synthetic modifications of this peptide fragment, combined with functional assays, enable the mapping of critical domains involved in receptor activation and signal transduction. Such research supports the rational design of novel peptide analogs and enhances the understanding of molecular determinants governing PTHrP's diverse biological actions.
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More